Brilacidin from Innovation Pharmaceuticals mimics antimicrobial peptides to combat pathogens and protect against antiviral activity.


  • Effective
  • Safe to use


  • Pharmaceuticals

UN Sustainable Development Goals Addressed

  • Goal 3: Good Health & Wellbeing

The Challenge

Viruses that infect humans can become a worldwide threat that can put millions of lives at risk. Drug companies are always looking for ways to develop more effective vaccines as quickly as possible.

Innovation Details

Brilacidin is a synthetic, non-peptidic small molecule that mimics antimicrobial peptides. It has a unique 3-in-1 combination of antiviral, immune/anti-inflammatory, and antimicrobial components that kill pathogens swiftly, significantly reducing the likelihood of drug resistance developing. It also helps reduce inflammation and promotes healing.

Image: Innovation Pharmaceuticals / Copyright © - All rights reserved

Skeletal formula of Brilacidin.